M-LP, Mpv17-like Protein, Has a Peroxisomal Membrane Targeting Signal Comprising a Transmembrane Domain and a Positively Charged Loop and Up-regulates Expression of the Manganese Superoxide Dismutase Gene*

Reiko IidaDagger §, Toshihiro Yasuda, Etsuko TsubotaDagger , Hisakazu TakatsukaDagger , Mika MasuyamaDagger , Takasumi MatsukiDagger , and Koichiro Kishi||

From the Departments of Dagger  Forensic Medicine and  Biology, Fukui Medical School, Fukui 910-1193, Japan and the || Department of Legal Medicine, Gunma University School of Medicine, Gunma 371-8511, Japan

Received for publication, October 24, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

M-LP (Mpv17-like protein) has been identified as a new protein that has high sequence homology with Mpv17 protein, a peroxisomal membrane protein involved in the development of early onset glomerulosclerosis. In this study, we verified the peroxisomal localization of M-LP by performing dual-color confocal analysis of COS-7 cells cotransfected with green fluorescent protein-tagged M-LP and DsRED2-PTS1, a red fluorescent peroxisomal marker. To characterize the peroxisomal membrane targeting signal, we examined the intracellular localizations of several green fluorescent protein-tagged deletion mutants and demonstrated that, of the three transmembrane segments predicted, the first near the NH2 terminus and NH2-terminal half of the following loop region, which is abundant in positively charged amino acids, were necessary and sufficient for peroxisomal targeting. To elucidate the function of M-LP, we examined the activities of several enzymes involved in reactive oxygen species metabolism in COS-7 cells and found that transfection with M-LP increased the superoxide dismutase activity significantly. Quantitative real-time PCR analysis revealed that the manganese SOD (SOD2) mRNA level of COS-7 cells transfected with M-LP was elevated. These results indicate that M-LP participates in reactive oxygen species metabolism.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The Mpv17-like protein (M-LP)1 gene was identified on the basis of an expressed sequence tag obtained by differential display screening of age dependently expressed genes in mouse kidneys (1, 2). The M-LP gene is expressed mainly in the kidney and spleen and the amount expressed increases steadily during development, reaches its highest level in adulthood, and decreases gradually with aging. It encodes 194 amino acids of a polypeptide with a sequence and membrane topology markedly similar to those of two peroxisomal membrane proteins, Mpv17 protein (3) (30.4% identity, 66.7% similarity) and PMP22 (4) (25.0% identity, 72.1% similarity). These results suggest that M-LP might be embedded in the peroxisomal membrane in a similar manner to these two proteins.

Peroxisomes are ubiquitous eukaryotic subcellular organelles that play essential roles in a variety of metabolic pathways, including H2O2 metabolism and the oxidative degradation of fatty acids (5). Recently, a number of studies have been carried out to investigate the mechanisms of peroxisomal biogenesis and protein import (6-8). Targeting of peroxisomal matrix proteins is mediated by cytosolic receptors Pex5p and Pex7p that recognize the peroxisomal targeting signals PTS1, which consists of the sequence SKL (and conservative variants) at the carboxyl terminus (9, 10), and PTS2, which consists of the consensus sequence (R/K)(L/V/I)X5(H/Q)(L/A) near the amino terminus (11, 12), respectively. Whereas the targeting of peroxisomal matrix protein import has been well characterized, neither conclusive consensus sequence nor the receptor(s) involved in peroxisomal membrane protein targeting have been determined. Thus, it is important to characterize the membrane peroxisome targeting signals (mPTSs) in as many peroxisomal membrane proteins as possible to understand the biogenesis of peroxisomal membranes.

The Mpv17-negative mouse strain was generated by inserting a defective retrovirus into the germ line of mice and is characterized by progressive glomerulosclerosis and neurosensory deafness at a young age (3, 13). The phenotype results from loss of function of the Mpv17 gene encoding a 20-kDa peroxisomal membrane protein. The molecular function of the Mpv17 protein has yet to be elucidated, but it was recently hypothesized that it plays an important role in peroxisomal reactive oxygen species (ROS) metabolism and that glomerular damage is because of overproduction of ROS. In Mpv17 gene-inactivated mice, a significant increase in ROS and lipid peroxidation adduct production was observed and oxygen radical scavengers prevented glomerular damage (14). Moreover, a recent study showed that the gamma -glutamyl transpeptidase enzyme activity and mRNA expression level were higher, whereas plasma glutathione peroxidase (Gpx3) and superoxide dismutase (SOD) activities were lower, in Mpv17 null cells than normal cells (15). These results strongly suggest that the Mpv17 protein is involved in enzymatic antioxidant defense systems. The aims of this study were first, to confirm the peroxisomal localization of M-LP and characterize the mPTS of this new protein and second, to investigate the activities and expression of antioxidant enzymes to determine whether there is a connection between M-LP and ROS metabolism.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Expression Vectors for the Peroxisomal Forms of Fluorescent Proteins-- All the primers used for expression vector construction in this study are listed in Table I. Green fluorescent protein (GFP)-PTS1 was amplified by the PCR using the primer set exGFPS and GFPPTS1A and pEGFP (Clontech, Palo Alto, CA) as the template. DsRED2-PTS1 was amplified using the primer set DsREDS and DsREDPTS1A and pDsRED2 (Clontech) as the template. The PCR products were cloned into the EcoRI/BamHI sites of a mammalian expression vector, pcDNA3.1 (Invitrogen, Carlsbad, CA).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Synthetic oligonucleotide primers used for construction of expression vectors
The start (ATG) and stop (TAA, TGA) codens are underlined, EcoRI, BamHI, HindIII, and KpnI sites are shown in lower case, and nucleotides altered (GFP-PTS1) or appended (DsRED2-PTS1) to create PTS1 (serine-lysine-leucine) are shown in bold.

Expression Vectors for M-LP-- A DNA fragment encoding full-length M-LP was created by PCR amplification using the primer set exMLPS2 and exMLPA2 and first-strand cDNA synthesized using the total RNAs from the kidneys of 9-month-old mice as the template. The PCR product was cloned into the EcoRI/BamHI sites of pcDNA3.1 (the resulting vector was designated pcDNA3.1/MLP). GFP tagging of the COOH or NH2 terminus of M-LP was done using a PCR gene fusion technique (16) as follows. To produce MLP-GFP (COOH-terminal GFP-tagged M-LP), two separate PCRs to amplify the M-LP and GFP genes were performed: the M-LP gene was amplified using the primer set exMLPS2 and exMG1A2 and first-strand cDNA synthesized using the total RNAs from the kidneys of 9-month-old mice as the template and the GFP gene was amplified using the primer set exMG2S and exGFPA and pEGFP as the template. Then, the two PCR products were mixed with the primer set exMLPS2 and exGFPA and extended by the PCR to form the chimeric gene. Likewise, to produce GFP-MLP (NH2-terminal GFP-tagged M-LP), separate PCRs for GFP and M-LP gene amplification were performed with the two primer sets exGFPS and exGM1A and exGM2S and exMLPA, respectively. Then, the two PCR products were mixed with the primer set exGFPS and exMLPA, extended by the PCR and each PCR-amplified chimeric gene was cloned into the EcoRI/BamHI site of pcDNA3.1 (the resulting vectors were designated pcDNA3.1/MLP-GFP and pcDNA3.1/GFP-MLP, respectively).

Expression Vectors for M-LP Variants-- NH2-terminal truncated Delta 15MLP-GFP (NH2-terminal amino acids 1-15 are deleted from M-LP), Delta 34MLP-GFP (NH2-terminal amino acids 1-34 are deleted), and Delta 91MLP-GFP (NH2-terminal amino acids 1-91 are deleted) were generated by the PCR using the primer pair sets 16MGS and exGFPA, 35MGS and exGFPA, or 92MGS and exGFPA, respectively, and pcDNA3.1/MLP-GFP as the template. The PCR products were cloned into the EcoRI/BamHI site of pcDNA3.1. COOH-terminal truncation variants 34MLP-GFP (comprising NH2-terminal amino acids 1-34), 55MLP-GFP (comprising NH2-terminal amino acids 1-55), 91MLP-GFP (comprising NH2-terminal amino acids 1-91), and an NH2- and COOH-terminal truncation variant 16/55MLP-GFP (comprising amino acids 16-55) were generated as follows. The GFP gene was PCR-amplified using the primer set exGFPS and exGFPA and pEGFP as the template and the PCR product was cloned into the EcoRI/BamHI sites of pcDNA3.1 (the resulting vector was designated pcDNA3.1/GFP). DNA fragments encoding amino acids 1-34, 1-55, 1-91, and 16-55 of M-LP were PCR amplified using the primer sets 91MS and 34MA, 91MS and 55MA, 91MS and 91MA, or 15DMS and 55MA, respectively, and pcDNA3.1/GFP-MLP as the template. The PCR products were cloned into the KpnI/HindIII sites of pcDNA3.1/GFP, which contained the coding sequence of GFP behind the KpnI/HindIII site.

Cells and Transfections-- COS-7 cells were maintained in Dulbecco's modified Eagle's medium containing 1 mM L-glutamine, 50 units/ml penicillin, 50 µg/ml streptomycin, and 10% (v/v) fetal calf serum (Invitrogen) and transiently transfected using LipofectAMINE Plus reagent (Invitrogen), according to the manufacturer's instructions.

Confocal Microscopy-- Cells were plated in 3.5-cm poly-D-lysine-coated glass-bottomed dishes (MatTek, Ashland, MA) and 24 h after transfection, fluorescent images were analyzed by a laser scanning confocal microscope LSM-GB200 (Olympus, Tokyo, Japan). An argon laser at 488 nm was used for excitation and the fluorescent signals emitted by GFP and DsRED2 were detected using a 535-nm band-pass filter and a 570-nm long pass filter, respectively.

Generation of Anti-M-LP Antibodies-- The cDNA encoding NH2-terminal amino acids 1-103 or COOH-terminal amino acids 105-194 of M-LP were cloned in-frame with glutathione S-transferase into the pGEX-6P-1 vector (Amersham Biosciences, Tokyo, Japan), introduced into Escherichia coli INValpha F' (Invitrogen), and induced using standard procedures. The glutathione S-transferase fusion proteins were solubilized from inclusion bodies using 8 M urea and affinity purified using glutathione-Sepharose-4B (Amersham Biosciences). For antibody production, the glutathione S-transferase fusion proteins were emulsified with adjuvant (TiterMax Gold; CytRx, Atlanta, GA), injected intramuscularly into Japanese white rabbits three times and the immunoglobulin G fractions were purified using a protein A column (Hitrap Protein A; Amersham Biosciences).

Enzyme Assays-- The activities of enzymes involved in ROS metabolism in COS-7 cells transfected with pcDNA3.1/MLP and pcDNA3.1 as a control were determined. Three days after transfection, culture media and cell lysates were recovered and their enzymatic activities were determined. The cell lysates used for the measurement of SOD and Gpx activities were prepared by mixing them with 250 mM Tris-HCl (pH 7.5) containing 500 µM phenylmethylsulfonyl fluoride and 1 µg/ml aprotinin and subjecting them to three freeze-thaw cycles, after which the SOD and Gpx activities were assayed using a SOD assay kit-WST (Dojin Molecular Technologies, Kumamoto, Japan) and a glutathione peroxidase assay kit (Cayman, Ann Arbor, MI), respectively. To investigate the effects of the anti-M-LP antibody on the SOD activities, cell lysates were incubated with antibody serially diluted with 25 mM Tris-HCl (pH 7.4) containing 8% (w/v) sodium chloride and 0.2% (w/v) potassium chloride at 37 °C for 1 h and the remaining activities were measured.

Cell lysates were prepared for the measurement of catalase (CAT) activity as follows. The cells were washed with phosphate-buffered saline (pH 7.4), suspended in phosphate-buffered saline containing 5 mM EDTA, 0.01% (w/v) digitonin, and 0.25% (w/v) sodium cholate and sonicated 30 s for 8-10 times until the solution was cleared. The sonicated sample was centrifuged at 12,000 × g for 30 min at 4 °C to remove cell debris and the catalase activity of the supernatant was measured using a BIOXYTECH Catalase-520 kit (OxisResearch, Portland, OR). Protein concentrations were determined using a QuantiPro BCA assay kit (Sigma). The data shown are mean ± S.E. Differences between means were determined using Student's t test and those at p < 0.05 were considered significant.

Measurement of mRNA Levels-- Total RNA from mouse kidneys was prepared as described in our previous report (1) and total RNA was extracted from COS-7 cells using Sepasol-RNA I Super (Nacalai Tesque, Kyoto, Japan), according to the manufacturer's instructions. The mRNA levels were determined by quantitative real-time PCR analysis with a LightCycler Instrument (Roche Molecular Diagnostics) using the QuantiTect SYBR Green PCR kit (Qiagen, Chatsworth, CA) as previously described (17). The primer sequences and product size for each gene are summarized in Table II. The amount of mRNA was normalized to the internal control, glyceraldehyde-3-phosphate dehydrogenase. All PCR assays were performed in triplicate and the intra-assay variability was <7%.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Primers for quantitative real-time PCR analyses


    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

M-LP Localizes to Peroxisomes-- A peroxisomal localization of M-LP was considered highly likely in view of the significant homology with both the amino acid sequences (30.4% identity, 66.7% similarity) and hydrophilicity profile of the peroxisomal membrane protein Mpv17. Accordingly, colocalization analysis of GFP-tagged M-LP and a peroxisomal marker protein was performed. First, the effectiveness of DsRED2-PTS1 as a peroxisomal marker was tested. Punctate fluorescence signals were observed in cells expressing DsRED2-PTS1 and they colocalized completely with the signals because of GFP-PTS1 (Fig. 1A), which has been used as a peroxisomal marker in previous studies (18, 19), whereas diffuse cytosolic fluorescence was observed in control cells expressing DsRED2. These results demonstrate that DsRed2-PTS1, as well as GFP-PTS1, is an effective marker for peroxisomal protein. Next, cells were co-transfected with DsRED2-PTS1 and either MLP-GFP or GFP-MLP and their intracellular distributions were examined (Fig. 1B). Punctate green fluorescence because of MLP-GFP was observed in MLP-GFP-expressing cells and was superimposable on the red fluorescence because of DsRED2-PTS1, demonstrating clearly that M-LP was targeted to peroxisomes. However, GFP-MLP was detected in peroxisomes and the cytoplasm. These results could be interpreted as meaning that the mPTS exists around the NH2-terminal and the interaction between the mPTS and its receptor(s) was hindered by tagging GFP onto the NH2 terminus of M-LP.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 1.   Colocalization analysis of GFP-tagged M-LP with DsRED2-PTS1, a fluorescent marker of peroxisomes. COS-7 cells were cotransfected with GFP-PTS1 and DsRED2-PTS1 (A), GFP-tagged M-LP and DsRED2-PTS1 (B), or GFP-tagged deletion mutants of M-LP and DsRED2-PTS1 (C), respectively. The fluorescent images because of GFP (green) and DsRED (red) were analyzed by a laser scanning confocal microscope.

The Transmembrane Segment 1 (TMS1) and NH2-terminal Half of the Loop between TMS1 and TMS2 Are Required for Peroxisomal Membrane Targeting-- To assess the mPTS of M-LP more closely, we constructed several NH2- and COOH-terminal deletion mutants, as shown in Fig. 2A, and examined their intracellular localizations (Fig. 1C). From the putative topology of M-LP derived from its primary structure, three TMSs, TMS1-(16-34), TMS2-(92-110), and TMS3-(151-168) have been predicted (2). Delta 15MLP-GFP, the mutant lacking the NH2-terminal tail consisting of the first 15 amino acids, was targeted properly to peroxisomes, as revealed by its colocalization with DsRED2-PTS1. However, the signals from cells expressing Delta 34MLP-GFP, which lacks the NH2-terminal tail and TMS1, did not correspond to peroxisomes, although several punctate signals were observed. In the case of Delta 91MLP-GFP, which lacks the NH2-terminal tail, TMS1, and the loop between TMS1 and TMS2, overall diffuse cytosolic fluorescence was observed. Next, in the cases of mutants truncated at the COOH-terminal region, 91MLP-GFP comprising residues 1-91, which include the NH2-terminal tail, TMS1, and the loop between TMS1 and TMS2, and 55MLP-GFP comprising residues 1-55, which include the NH2-terminal tail, TMS1, and half of the loop between TMS1 and TMS2, were located exclusively in peroxisomes, whereas 34MLP-GFP comprising residues 1-34, which include the NH2-terminal tail and TMS1, was partially localized in peroxisomes. These results demonstrate that TMS1 and the NH2-terminal half of the loop between TMS1 and TMS2 are required for the correct peroxisomal localization of M-LP. To confirm this hypothesis, 16/55MLP-GFP, comprising residues 16-55, which include TMS1 and the NH2-terminal half of the loop between TMS1 and TMS2, was constructed and its intracellular localization was examined. As shown in Fig. 1C, the signals were localized exclusively in peroxisomes, suggesting that TMS1 and the NH2-terminal half of the loop between TMS1 and TMS2 are sufficient to function as an mPTS.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Schematic presentation of deletion mutants and the peroxisome targeting signal of M-LP. A, localization to peroxisomes is indicated by: +, localized; ±, partially localized; -, not localized. B, positively charged amino acids in the loop between TMS1 and TMS2 are indicated by +. The region required for peroxisomal membrane targeting is indicated by a bar.

Although a great deal of information about peroxisomal matrix protein import has been obtained, our understanding of how peroxisomal membrane proteins are targeted and integrated into peroxisomal membranes is still poor. The sequences involved in targeting or insertion of peroxisomal membrane proteins described so far are as follows: in Pichia pastoris Pas2p (20) and human (21) and Hansenula polymorpha (22) Pex3p, positively charged amino acids at the NH2-terminal region were shown to be involved in targeting or insertion; in Saccharomyces cerevisiae Pex15p, the COOH-terminal luminal tail was required for targeting (23); in rat PMP70, an internal region that roughly corresponded to the TMS3 was necessary for targeting and insertion (24); in S. cerevisiae PMP47, TMS2 plus an adjacent cytoplasmic oriented sequence, a matrix facing basic cluster, and an anchoring TMS were sufficient for targeting (25); in human PMP34, the loop region between TMS4 and TMS5 and three transmembrane segments were required for targeting and insertion (26); and in rat PMP22, the NH2-terminal region and more than one TMS were required for targeting and insertion (27). Although the amino acid sequences of M-LP and PMP22 are very similar (25.0% identity, 72.1% similarity), those in the NH2-terminal regions are quite different and the mPTS identified in PMP22 was not found in M-LP. Honsyo and Fujiki (26) pointed out that no conclusive consensus sequence had been observed, but the feature common to most of these proteins was the presence of positively charged amino acids located in the flanking region of a TMS. From this point of view, M-LP has two clusters of positively charged amino acids in the loop between TMS1 and TMS2 (the first cluster at amino acid positions 37, 39, 46, 49, and 50; the second at positions 68, 72, 77, 80, and 85). Our results demonstrate that the presence of the NH2-terminal half of the loop containing the first cluster and adjacent TMS1 were sufficient for M-LP to function as an mPTS. Therefore, it can be said that M-LP satisfies the law these authors suggested.

SOD Activity Is Elevated in COS-7 Cells Transfected with M-LP-- The high sequence and membrane topological homologies of M-LP and Mpv17 have led to speculation that M-LP, as well as Mpv17, functions as an ROS scavenger. Accordingly, we determined the activities of enzymes involved in ROS metabolism in COS-7 cells transfected with pcDNA3.1/MLP and pcDNA3.1 as a control. As shown in Table III, there was no significant difference between the Gpx or CAT activities of these cells. However, the SOD activity of the cell lysates prepared from COS-7 cells transfected with M-LP was significantly higher than that of the control cells. The following two mechanisms may be responsible for the elevation of SOD activity: activation of SOD at the protein level and an increase in the amount of SOD enzyme expressed. However, in view of our finding that preincubation with an anti-M-LP antibody did not influence the SOD activity (data not shown), it seems unlikely that the SOD activity is regulated by an interaction with M-LP at the protein level.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Enzyme activities in COS-7 cells transfected with pcDNA3.1 and pcDNA3.1/MLP

Manganese-SOD (SOD2) mRNA Is Increased in COS-7 Cells Transfected with M-LP-- Three SOD isoforms, a cytosolic, copper-zinc SOD (SOD1), a mitochondrial, manganese SOD (SOD2), and an extracellular SOD (SOD3) have been detected in mammalian cells (27). The mRNA levels of these three SODs, cellular Gpx (Gpx1), Gpx3, and CAT in COS-7 cells transfected with M-LP were examined using quantitative real-time reverse transcriptase-PCR (Fig. 3). Whereas the expression levels of five genes (SOD1, SOD3, Gpx1, Gpx3, and CAT) were unchanged, an increase in SOD2 mRNA compared with the control cell level was observed, suggesting that the increase in SOD activity in the M-LP expressing cells was due mainly to up-regulation of the SOD2 gene. Recently, Wagner et al. (15) performed the reverse experiment, i.e. examination of the activities and mRNA levels of antioxidant enzymes in Mpv17 null cells, and found that the absence of the Mpv17 protein reduced expression of all three SOD isoforms and Gpx3 and concomitantly increased gamma -glutamyl transpeptidase expression. Therefore, M-LP seems to have the same function as the Mpv17 protein from the point of view that its action leads to a reduction in ROS production.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   The mRNA levels of enzymes involved in ROS metabolism in COS-7 cells transfected with M-LP. The mRNA levels of SOD1, SOD2, SOD3, Gpx1, Gpx3, and CAT in M-LP expressing cells (n = 4) were determined by quantitative real-time PCR analysis. The results are expressed as ratios relative to the value for the control cells transfected with pcDNA3.1 (n = 4). The increase in the SOD2 mRNA level was statistically significant (*, p = 0.028).

The Expression Patterns of SOD2 and M-LP Genes in Mouse Kidney during Development and Aging Are Similar-- In our previous study, we used comparative reverse transcriptase-PCR and showed that M-LP gene expression changed age-dependently (2). Our finding that M-LP affected expression of the SOD2 gene awoke our interest in the expression patterns of the SOD2 gene during development and aging. Therefore, the levels of M-LP and SOD2 mRNAs in the kidneys of 3-day- to 15-month-old mice were measured using quantitative real-time PCR. As shown in Fig. 4A, the amount of M-LP expressed increased steadily during development, reached its highest levels in adulthood and decreased gradually with aging. This observation agreed quite well with our previous results (2). As expected, the expression pattern of the SOD2 gene was very similar to that of M-LP (Fig. 4B), suggesting that M-LP participates in the regulation of SOD2 gene expression.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Age-dependent expression of M-LP (A) and SOD2 (B) mRNAs in mouse kidney detected by quantitative real-time PCR analysis. The results are expressed as percentages of the maximum mean value. D, day; W, week; M, month.

Age-dependent changes in SOD2 activity or its gene expression have been reported in several mammalian tissues. However, the expression patterns vary depending on species and/or tissues. For instance, SOD2 activity was observed to be lower in human skin fibroblast cell lines derived from fetal skin than those from postnatal skin, although no postnatal age-dependent differences were observed (29). Three-month-old rats had higher hepatic SOD2 activities than 24-month-old rats, whereas there was no significant age-related difference in the SOD2 activities of the lungs (30). In our previous study, we showed that the M-LP gene is expressed mainly in the kidney and spleen. The different expression patterns in various tissues may be attributable to the participation of a tissue-specific molecule like M-LP in the regulation of SOD2.

ROS are generated constantly during oxidative metabolism and cause cellular damage by reacting with proteins, lipids, DNA, and carbohydrates. SOD is considered to be one of the most important constituents of the first line of defense against ROS production by virtue of its ability to convert highly reactive superoxide radicals to hydrogen peroxide and molecular oxygen. Our data demonstrated that, of the three SODs, only the SOD2 gene was up-regulated by the expression of M-LP. The biological importance of SOD2 has been shown in studies on knockout mice (31, 32): homozygous mutant mice died less than 3 weeks after birth, probably because of severe impairment of mitochondrial function because of the elevated level of ROS (28). Analysis of the 5'-flanking region resulted in the identification of several regulatory sequences, including Sp1, NF-kappa B, CCAAT-enhancer binding protein, and an antioxidant-response element (33). Of the antioxidant enzymes, only SOD2 is induced by various stimuli, such as tumor necrosis factor-alpha (34), interleukin-1 (35), and X-irradiation (36) that are known to produce ROS or induce intracellular ROS generation. The mechanism responsible for the induction of SOD2 under these conditions has yet to be elucidated, however, it has been proposed that tumor necrosis factor-alpha and interleukin-1 regulate SOD2 expression by activating the transcription factor NF-kappa B (37, 38). Thus, further investigation is needed to clarify the relationship between M-LP and these factors and the role(s) of M-LP in ROS metabolism.

    ACKNOWLEDGEMENTS

We thank F. Nakamura for secretarial assistance. We also thank S. Ikeda and K. Ikeda for heartfelt encouragement.

    FOOTNOTES

* This work was supported in part by Japan Society for the Promotion of Science Grants-in-aid 12670390 (to R. I.), 12357003, 13877069 (to T. Y.), and 12307011 (to K. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 81-776-61-3111; Fax: 81-776-61-8108; E-mail: ireiko@fmsrsa.fukui-med.ac.jp.

Published, JBC Papers in Press, December 5, 2002, DOI 10.1074/jbc.M210886200

    ABBREVIATIONS

The abbreviations used are: M-LP, Mpv17-like protein; GFP, green fluorescent protein; ROS, reactive oxygen species; SOD, superoxide dismutase; PTS, peroxisome targeting signal; mPTS, peroxisome targeting signal of membrane protein; Gpx, glutathione peroxidase; CAT, catalase; TMS, transmembrane segment.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Iida, R., Yasuda, T., Aoyama, M., Tsubota, E., Matsuki, T., and Kishi, K. (2000) Mech. Ageing Dev. 113, 135-144[CrossRef][Medline] [Order article via Infotrieve]
2. Iida, R., Yasuda, T., Tsubota, E., Matsuki, T., and Kishi, K. (2001) Biochem. Biophys. Res. Commun. 283, 292-296[CrossRef][Medline] [Order article via Infotrieve]
3. Weiher, H., Noda, T., Gray, D. A., Sharpe, A. H., and Jaenisch, R. (1990) Cell 62, 425-434[Medline] [Order article via Infotrieve]
4. Bryant, D. D., and Wilson, G. N. (1995) Biochem. Mol. Med. 55, 22-30[CrossRef][Medline] [Order article via Infotrieve]
5. Van den Bosch, H., Schutgens, R. B., Wanders, R. J., and Tager, J. M. (1992) Annu. Rev. Biochem. 61, 157-197[CrossRef][Medline] [Order article via Infotrieve]
6. Erdmann, R., Veenhuis, M., and Kunau, W-H. (1997) Trends Cell Biol. 7, 400-407[CrossRef]
7. Passreiter, M., Anton, M., Lay, D., Frank, R., Harter, C., Wieland, F. T., Gorgas, K., and Just, W. W. (1998) J. Cell Biol. 141, 373-383[Abstract/Free Full Text]
8. Subramani, S. (1998) Physiol. Rev. 78, 171-188[Abstract/Free Full Text]
9. Gould, S. G., Keller, G. A., and Subramani, S. (1987) J. Cell Biol. 105, 2923-2931[Abstract]
10. Elgersma, Y., Kwast, L., Klein, A., Voorn-Brouwer, T., van den Berg, M., Metzig, B., America, T., Tabak, H. F., and Distel, B. (1996) J. Cell Biol. 135, 97-109[Abstract]
11. Swinkels, B. W., Gould, S. J., Bodnar, A. G., Rachubinski, R. A., and Subramani, S. (1991) EMBO J. 10, 3255-3262[Abstract]
12. Rehling, P., Marzioch, M., Niesen, F., Wittke, E., Veenhuis, M., and Kunau, W. H. (1996) EMBO J. 15, 2901-2913[Abstract]
13. Meyer zum Gottesberge, A. M., Reuter, A., and Weiher, H. (1996) Eur. Arch. Otorhinolaryngol. 253, 470-474[Medline] [Order article via Infotrieve]
14. Binder, C. J., Weiher, H., Exner, M., and Kerjaschki, D. (1999) Am. J. Pathol. 154, 1067-1075[Abstract/Free Full Text]
15. Wagner, G., Stettmaier, K., Bors, W., Sies, H., Wagner, E. M., Reuter, A., and Weiher, H. (2001) Biol. Chem. 382, 1019-1025[Medline] [Order article via Infotrieve]
16. Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 61-68[CrossRef][Medline] [Order article via Infotrieve]
17. Iida, R., Yasuda, T., Tsubota, E., Takatsuka, H., Masuyama, M., Matsuki, T., and Kishi, K. (2002) Exp. Gerontol. 37, 1121-1126[CrossRef][Medline] [Order article via Infotrieve]
18. Kalish, J. E., Keller, G. A., Morrell, J. C., Mihalik, S. J., Smith, B., Cregg, J. M., and Gould, S. J. (1996) EMBO J. 15, 3275-3285[Abstract]
19. Wiemer, E. A., Wenzel, T., Deerinck, T. J., Ellisman, M. H., and Subramani, S. (1997) J. Cell Biol. 136, 71-80[Abstract/Free Full Text]
20. Wiemer, E. A., Luers, G. H., Faber, K. N., Wenzel, T., Veenhuis, M., and Subramani, S. (1996) J. Biol. Chem. 271, 18973-18980[Abstract/Free Full Text]
21. Kammerer, S., Holzinger, A., Welsch, U., and Roscher, A. A. (1998) FEBS Lett. 429, 53-60[CrossRef][Medline] [Order article via Infotrieve]
22. Baerends, R. J., Faber, K. N., Kram, A. M., Kiel, J. A., van der Klei, I. J., and Veenhuis, M. (2000) J. Biol. Chem. 275, 9986-9995[Abstract/Free Full Text]
23. Elgersma, Y., Kwast, L., van den Berg, M., Snyder, W. B., Distel, B., Subramani, S., and Tabak, H. F. (1997) EMBO J. 16, 7326-7341[Abstract/Free Full Text]
24. Imanaka, T., Shiina, Y., Takano, T., Hashimoto, T., and Osumi, T. (1996) J. Biol. Chem. 271, 3706-3713[Abstract/Free Full Text]
25. Wang, X., Unruh, M. J., and Goodman, J. M. (2001) J. Biol. Chem. 276, 10897-10905[Abstract/Free Full Text]
26. Honsho, M., and Fujiki, Y. (2001) J. Biol. Chem. 276, 9375-9382[Abstract/Free Full Text]
27. Pause, B., Saffrich, R., Hunziker, A., Ansorge, W., and Just, W. W. (2000) FEBS Lett. 471, 23-28[CrossRef][Medline] [Order article via Infotrieve]
28. Przedborski, S., and Schon, E. A. (1998) Nat. Genet. 18, 99-100[CrossRef][Medline] [Order article via Infotrieve]
29. Allen, R. G., Keogh, B. P., Gerhard, G. S., Pignolo, R., Horton, J., and Cristofalo, V. J. (1995) J. Cell. Physiol. 165, 576-587[Medline] [Order article via Infotrieve]
30. Santa Maria, C., Ayala, A., and Revilla, E. (1996) Free Radical Res. 25, 401-405[Medline] [Order article via Infotrieve]
31. Li, Y., Huang, T. T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., Wallace, D. C., and Epstein, C. J. (1995) Nat. Genet. 11, 376-381[Medline] [Order article via Infotrieve]
32. Lebovitz, R. M., Zhang, H., Vogel, H., Cartwright, J., Jr., Dionne, L., Lu, N., Huang, S., and Matzuk, M. M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 9782-9787[Abstract/Free Full Text]
33. Jones, P. L., Kucera, G., Gordon, H., and Boss, J. M. (1995) Gene (Amst.) 153, 155-161[CrossRef][Medline] [Order article via Infotrieve]
34. Wong, G. H., and Goeddel, D. V. (1988) Science 242, 941-944[Medline] [Order article via Infotrieve]
35. Masuda, A., Longo, D. L., Kobayashi, Y., Appella, E., Oppenheim, J. J., and Matsushima, K. (1988) FASEB J. 2, 3087-3091[Abstract/Free Full Text]
36. Akashi, M., Hachiya, M., Paquette, R. L., Osawa, Y., Shimizu, S., and Suzuki, G. (1995) J. Biol. Chem. 270, 15864-15869[Abstract/Free Full Text]
37. Das, K. C., Lewis-Molock, Y., and White, C. W. (1995) Am. J. Physiol. 269, L588-L602[Abstract/Free Full Text]
38. Maehara, K., Hasegawa, T., and Isobe, K. I. (2000) J. Cell. Biochem. 77, 474-486[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.